PharmaLundensis AB (publ) operates as a pharmaceutical company in Sweden. It is conducting a clinical trial for the treatment of chronic obstructive pulmonary disease, a severe lung disease; and completed a clinical study for the treatment of chronic fatigue syndrome. The company was founded in 2006 and is based in Lund, Sweden.
pharmalundensis ab (PHAL:Stockholm)
Lund, 223 81
Phone: 46 46 13 27 78
Fax: 46 46 13 27 79www.pharmalundensis.se
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for PHAL.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact PHARMALUNDENSIS AB, please visit www.pharmalundensis.se. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.